Investigational New Drug (IND) Submission Readiness

Investigational New Drug (IND) Submission Readiness

Thank you for participating in Car-T Global Week. Here you can access the recording of January 25's workshop on Investigational New Drug (IND) Submission Readiness.

Details: Take part in a workshop to ensure preparedness for the process for IND applications submission with leaders from academia as well as FDA reviewers.

Speakers:

  • Anne Chew Executive Deputy Director, Center for Cellular Immunotherapies University of Pennsylvania- Penn Medicine
  • Shana Hardy Biologist, Office of Tissues and Advanced Therapies Division of Clinical Evaluation and Pharm/Tox FDA/CBER
  • Tal Salz PhD Cell and Gene Therapy Reviewer, Office of Tissues and Advanced Therapies Division of Cellular and Gene Therapies Food and Drug Administration (FDA)/CBER

Please note: That all fields marked with an asterisk (*) are required.



This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.